Omalizumab in severe asthma with seasonal allergic sensitization

被引：0
作者：
Tuerk, M. [1 ,3 ]
Tutar, N. [2 ]
Yilmaz, I. [1 ]
机构：
[1] Erciyes Univ, Sch Med, Dept Chest Dis, Div Allergy & Clin Immunol, Kayseri, Turkiye
[2] Erciyes Univ, Sch Med, Dept Chest Dis, Kayseri, Turkiye
[3] Erciyes Univ, Erciyes Univ Hastanesi, Dept Chest Dis, Div Allergy & Clin Immunol,Sch Med, Feyzioglu Cad 42, TR-38039 Melikgazi Kayseri, Turkiye
来源：
REVUE FRANCAISE D ALLERGOLOGIE | 2023年 / 63卷 / 05期
关键词：
Pollen allergy; Severe asthma; Omalizumab;
D O I：
10.1016/j.reval.2023.103675
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma
    Frix, A. N.
    Schleich, F.
    Paulus, V
    Guissard, F.
    Henket, M.
    Louis, R.
    BIOCHEMICAL PHARMACOLOGY, 2020, 179
  • [42] Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma
    Kopp, M. V.
    Hamelmann, E.
    Zielen, S.
    Kamin, W.
    Bergmann, K. -C.
    Sieder, C.
    Stenglein, S.
    Seyfried, S.
    Wahn, U.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (02) : 271 - 279
  • [43] Influence of Staphylococcal enterotoxin-specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma
    Weng, Chih-Ming
    Wu, Wei-Ciao
    Lee, Meng-Jung
    Chen, Mei-Chuan
    Chou, Chun-Liang
    Lin, Chun-Yu
    Chung, Kian Fan
    Kuo, Han-Pin
    RESPIROLOGY, 2024, 29 (03) : 252 - 255
  • [44] Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma
    Bousquet, J.
    Siergiejko, Z.
    Swiebocka, E.
    Humbert, M.
    Rabe, K. F.
    Smith, N.
    Leo, J.
    Peckitt, C.
    Maykut, R.
    Peachey, G.
    ALLERGY, 2011, 66 (05) : 671 - 678
  • [45] Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recoveryELISA
    Jens-Oliver Steiß
    G. Becher
    BioDrugs, 2014, 28 : 445 - 450
  • [46] Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
    Torres-Duque, Carlos A.
    Ocampo-Gomez, Jaime
    Castillo, Mauricio Morales
    Cano-Rosales, Diana
    Giraldo-Montoya, Angela
    Rodriguez, Freddy
    Palacios-Ortega, Isabel
    Duran-Silva, Mauricio
    Reynales, Humberto
    Garcia, Elizabeth
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [47] Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
    Carlos A. Torres-Duque
    Jaime Ocampo-Gómez
    Mauricio Morales Castillo
    Diana Cano-Rosales
    Ángela Giraldo-Montoya
    Freddy Rodríguez
    Isabel Palacios-Ortega
    Mauricio Durán-Silva
    Humberto Reynales
    Elizabeth García
    BMC Pulmonary Medicine, 22
  • [48] Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype
    Rojo-Tolosa, Susana
    Sanchez-Martinez, Jose Antonio
    Pineda-Lancheros, Laura Elena
    Galvez-Navas, Jose Maria
    Gonzalez-Gutierrez, Maria Victoria
    Jimenez-Galvez, Gonzalo
    Perez-Ramirez, Cristina
    Morales-Garcia, Concepcion
    Jimenez-Morales, Alberto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [49] Response to omalizumab in patients with severe allergic asthma: A real-life study
    Zierau, Louise
    Waisted, Emil Schwarz
    Thomsen, Simon Francis
    Backer, Vibeke
    RESPIRATORY MEDICINE, 2017, 131 : 109 - 113
  • [50] Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma
    Kulus, M.
    Hebert, J.
    Garcia, E.
    Taylor, A. Fowler
    Vidaurre, C. Fernandez
    Blogg, M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (06) : 1285 - 1293
12345